Unlike prescription and over-the-counter drugs, dietary supplements do not require FDA approval before they reach the market. According to the NIH Office of Dietary Supplements, supplement companies are responsible for having evidence that their products are safe and that label claims are truthful, but as long as the product does not make a disease claim, it can be sold without any pre-market clinical review. For anyone evaluating a finished formulation, understanding that regulatory context changes how you read an ingredient list.
1. An ingredient list is a roster, not a result.
Listing five well-researched compounds in a capsule does not tell you how those compounds perform together. Nutrient synergy is the concept that the combined physiological effects of two or more nutrients can be greater than those of each nutrient consumed individually. It’s an established area of nutritional science that requires specific conditions to occur.
Dose, delivery format, and the presence of co-factors all influence whether two compounds amplify each other or do nothing in combination. A formula that lists the right ingredients at the wrong ratios, or in a delivery form that affects how they are absorbed, may not produce the same outcome as studies on those individual ingredients would suggest.
2. Ingredients can also work against each other.
According to the National Academies of Sciences, interactions between supplement ingredients and other ingested substances can result in increases or decreases in the level of a compound in the body, or in combined effects that single-ingredient data would not have predicted.
Research published in Toxicology Research and Application notes that micronutrients may not act efficiently in isolation and that combined compounds in a food matrix can have synergistic or competing effects depending on how they interact during absorption and metabolism. This is why studying ingredients in isolation produces a fundamentally different data set than studying the finished formula as a unit.
3. Structure-function claims do not require finished-product trials.
The FTC doesn’t specifically require clinical trials for dietary supplement health or structure-function claim substantiation, though claims must be supported by competent and reliable scientific evidence.
In practice, the bar is often met by citing existing ingredient literature rather than conducting trials on the complete formula. A supplement can carry health-supporting language on its label while the only published research behind it was conducted on isolated compounds, sometimes at doses or in delivery forms different from what is in the product itself.
4. Formulation-specific research produces a different category of answer.
When a study uses the finished product at the intended dose and in its commercial form, the results speak directly to what a consumer is purchasing. Joel Kahn, MD, an integrative cardiologist at the Kahn Center for Cardiac Longevity, describes the standard he applies when evaluating options for patients. He says, “When recommending supplements to patients, I’m greatly influenced by the presence of well-conducted clinical studies—even if they’re small. This way, there’s at least a protocol, a peer-reviewed publication, or other material to evaluate.”
Calroy Health Sciences followed this approach with Arterosil HP® with MonitumRS®, commissioning formulation-specific research. Central to that work was the screening of rhamnan sulfate derived from Monostroma nitidum, a rare green seaweed compound, using a patented microfluidic chip technology that simulates conditions inside living blood vessels. This approach was designed to evaluate how candidate compounds interact with the endothelial glycocalyx, the micro-thin inner lining of blood vessels, before advancing to human studies.
5. CGMP certification and clinical research answer two different questions.
Current Good Manufacturing Practice (CGMP) certification confirms that a product contains what its label states, in the amounts listed, produced under quality-controlled conditions. It is a manufacturing standard.
By contrast, drug approval requires the FDA to determine that a product is both safe and effective based on substantial evidence from laboratory studies and clinical trials before it can be marketed, a threshold that supplements are not held to. Seeing a CGMP seal on a supplement label tells you the product was made correctly, but it says nothing about whether the formula was tested in human subjects and shown to produce a measurable outcome.
As Kahn put it: “Even a small effort in clinical research will always be less rigorous than FDA drug testing, which varies based on study size and costs, creating a large divide between average supplements and those backed by meaningful research that should be recommended in practice.” That divide does not show up on the label.
FAQ
What does “nutrient synergy” mean in the context of supplements?
Nutrient synergy describes how two or more compounds consumed together can produce a combined physiological effect greater than what each would produce individually. Whether synergy occurs depends on dose, delivery format, and co-factors. This is why studying ingredients separately does not confirm that a finished multi-ingredient formula will produce the same effects.
What is the endothelial glycocalyx?
The endothelial glycocalyx is a thin gel-like layer coating the inner surface of every blood vessel in the body. It functions as a semi-permeable barrier between circulating blood and vessel walls, regulates what passes into vessel tissue, supports nitric oxide production, and houses protective enzymes that support vascular integrity.
What is the difference between CGMP certification and clinical research on a supplement?
CGMP certification confirms a product was manufactured under quality-controlled conditions and contains what the label states. Clinical research tests whether the formula as a whole produces a measurable biological effect in human subjects. The two address entirely separate questions, and one does not substitute for the other.
What is rhamnan sulfate?
Rhamnan sulfate is a sulfated polysaccharide derived from Monostroma nitidum, a rare green seaweed. It has been studied for its structural relationship to the endothelial glycocalyx, the inner lining of blood vessels.
What should I ask before purchasing a supplement?
Ask whether the research cited was conducted on the finished formula or only on individual ingredients, whether those studies involved human subjects, and whether results were peer-reviewed. A clinical trial registration number or a published citation tied to the actual product is a stronger signal than general ingredient science.
<
Leave a Reply